Long term risk stratification of patients with acute coronary syndromes: Characteristics of troponin T testing and continuous ST segment monitoring

Heart

Volumn 90, Issue 7, 2004, Pages 739-744

  Norgaard B L ^a   Andersen, K ^b   Thygesen, K ^a   Ravkilde, J ^a   Abrahamsson, P ^b   Grip, L ^b   Dellborg, M ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TROPONIN T;

ACUTE DISEASE; ACUTE HEART INFARCTION; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE MARKER; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART DEATH; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN DETERMINATION; RISK ASSESSMENT; ST SEGMENT; VECTORCARDIOGRAPHY;

EID: 3042689547     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2003.020479     Document Type: Article

References (39)

1. Wu AHB, Abbas SA, Green S, et al. Prognostic value of cardiac troponin T in unstable angina pectaris. Am J Cardiol 1995;76:970-2.
2. Ravkilde J, Nissen H, Hørder M, et al. Independent prognostic value of serum creatine kinase isoenzyme MB mass, cardiac tropanin T and myosin light chain levels in suspected acute myocardial infarction. Analysis of 28 months follow-up in 196 patients. J Am Coll Cardiol 1995;25:574-81.
3. Ohman EM, Armstrong PW, Christenson RH, et al. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. N Engl J Med 1996;335:1333-41.
4. Stubbs P, Collinson P, Mosely D, et al. Prognostic significance of admission troponin T concentrations in patients with myocardial infarction. Circulation 1996;94:1291-7.
5. Stubbs P, Collinson P, Mosely D, et al. Prospective study of the role of cardiac troponin T in patients admitted with unstable angina. BMJ 1996;313:262-4.
6. Lüscher MS, Thygesen K, Ravkilde J, et al for the TRIM Study Group. Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease. Circulation 1997;96:2578-85.
7. Holmvang L, Lüscher MS, Clemmensen P, et al. Very early risk stratification using combined ECG and biochemical assessment in patients with unstable coronary artery disease (a thrombin inhibition in myocardial ischemia [TRIM] substudy). Circulation 1998;98:2004-9.
8. Lindohl B, Toss H, Siegbohn A, et al. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. N Engl J Med 2000;343:1139-47.
9. Gottlieb SO, Weisfeldt ML, Ouyang P, et al. Silent ischemia predicts infarction and death during 2 year follow-up of unstable angina. J Am Coll Cardiol 1987;10:756-60.
10. Langer A, Freeman MR, Armstrong PW. ST segment shift in unstable angina: pathophysiology and association with coronary anatomy and hospital outcome. J Am Coll Cardiol 1989;13:1495-502.
11. Romeo F, Rosano GM, Martuscelli E, et al. Unstable angina: role of silent ischemia and total ischemic time (silent+painful ischemia), a 6-year follow-up. J Am Coll Cardiol 1992;19:1173-9.
12. Dellborg M, Malmberg K, Ryden L, et al. Dynamic on-line vectorcardiography improves and simplifies in hospital ischemia monitoring of patients with unstable angina. J Am Coll Cardiol 1995;26:1501-7.
13. Andersen K, Eriksson P, Dellborg M. Non-invasive risk stratification within 48 hours of hospital admission in patients with unstable coronary disease. Eur Heart J 1996;18:780-8.
14. Pertel DJ, Knight DR, Holdright D, et al. Long term prognosis in unstable angina: the importance of early risk stratification using continuous ST segment monitoring. Eur Heart J 1998;19:240-9.
15. Nørgaard BL, Andersen K, Dellborg M, et al. Admission risk assessment by cardiac troponin T in unstable coronary artery disease: additional prognostic information from continuous ST segment monitoring. J Am Coll Cardiol 1999;33:1519-27.
16. Jernberg T, Lindahl B, Wallentin L. The combination of a continuous 12-lead ECG and tropanin T: a valuable tool for risk stratification during the first 6 hours in patients with chest pain and non-diagnostic ECG. Eur Heart J 2000;21:1464-72.
17. Anon. A low-molecular-weight, selective thrombin inhibitor, inogatran, versus heparin in unstable coronary artery disease in 1209 patients: a double blind, randomised, dose-finding study. Thrombin inhibition in myocardial ischemia (TRIM) study group. Eur Heart J 1997;18:1416-25.
18. Müller-Bordoff M, Hallermayer K, Schröder A, et al. Improved tropanin T ELISA specific for cardiac tropanin T isoform: assay development and analytical and clinical validation. Clin Chem 1997;43:458-66.
19. Anon. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. Fragmin and fast revascularisation during instability in coronary artery disease investigators. Lancet 1999;354:708-15.
20. Morrow DA, Cannon CO, Rifai N, et al. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction. JAMA 2001;286:2405-12.
21. Diderholm E, Andren B, Frostfeldt G, et al. ST depression in ECG at entry indicates severe coronary lesions and large benefits of an early invasive treatment strategy in unstable coronary artery disease. The FRISC II ECG substudy. Eur Heart J 2002;23:41-9.
22. Braunwald E, Mark DB, Jones RH, et al. Unstable angina: diagnosis and management. Clinical practice guideline number 10 [AHCPR publication no 94-0602]. Rockville: Agency for Health Care Policy and Research and the National Heart, Lung, and Blood Institute, Public Health Service, US Department of Health and Human Services, 1994.
23. Falk E, Shah PK, Fusfer V. Coronary plaque disruption. Circulation 1995;92:657-71.
24. Bogaty P, Hackett D, Davies G, et al. Vasoreactivity of the culprit lesion in unstable angina. Circulation 1994;90:5-11.
25. Capone G, Wolf NM, Meyer B, et al. Frequency of intracoronary filling defects by angiography in angina at rest. Am J Cardiol 1985;56:403-6.
26. Califf RM, Phillips HR 3rd, Hindman MC, et al. rognostic value of a coronary artery jeopardy score. J Am Coll Cardiol 1985;5:1055-63.
27. Freeman MR, Williams AE, Chisholm RJ, et al. Intracoronary thrombus and complex morphology in unstable angina: relation to timing of angiography and in-hospital cardiac events. Circulation 1989;80:17-23.
28. Bugiadini R, Pozzati A, Borghi A, et al. Angiographic morphology in unstable angina and its relation to transient myocardial ischemia and hospital outcome. Am J Cardiol 1991;67:460-4.
29. Heeschen C, van den Brand MJ, Hamm CW, et al. Angiographic findings in patients with refractory unstable angina according to troponin T status. Circulation 1999;104:1509-14.
30. Newby LK, Kaplan AL, Granger BB, et al. Comparison of cardiac troponin T versus creatine kinase-MB for risk stratification in a chest pain evaluation unit. Am J Cardiol 2000;85:801-5.
31. Lindahl B, Diderholm E, Lagerqvist B, et al. Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II study. J Am Coll Cardiol 2001;38:879-86.
32. Patel DJ, Gomma AH, Knight C.J., et al. Why is recurrent myocardial ischaemia a predictor of adverse outcome in unstable angina? An observational study of myocardial ischemia and its relation to coronary anatomy. Eur Heart J 2001;22:1991-6.
33. Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation 1985;71:699-708.
34. Topol EJ, Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 2000;101:570-80.
35. Lindahl B, Venge P, Wallentin L. Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. J Am Coll Cardiol 1997;29:43-8.
36. Hamm CW, Heeschen C, Goldmann B, et al. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. N Engl J Med 1999;340:1623-9.
37. Chai AU, Crawford MH. "Traditional" medical therapy in unstable angina: how important? How to use? Cardiol Clin 1999;17:359-72.
38. Rao AC, Collison PO, Canepa-Anson R, et al. Troponin T measurement after myocardial infarction can identify left ventricular ejection of less than 40%. Heart 1998;80:223-5.
39. St John Sutton M, Pfeffer MA, Plappert T, et al. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction: the protective effects of captopril. Circulation 1994;89:68-75.